Picture EBD Group World of Partnering Opportunities 650x100px
Organisation › Details


CSL (ASX: CSL; USOTC:CSLLY) is a leading global biotechnology company with a dynamic portfolio of life-saving medicines, including those that treat hemophilia and immune deficiencies, as well as vaccines to prevent influenza. Since our start in 1916, we have been driven by our promise to save lives using the latest technologies. Today, CSL — including our two businesses, CSL Behring and Seqirus- provides life-saving products to more than 100 countries and employs more than 25,000 people. Our unique combination of commercial strength, R&D focus and operational excellence enables us to identify, develop and deliver innovations so our patients can live life to the fullest *


Period Start 1997-08-29 existent
Period End 1997-08-29 existent
  Group CSL (Group)
Product Industry pharmaceutical
Region Region Australia_oooo
  Country Australia
  Street 45 Poplar Road
  City 3052 Parkville VIC
    Address record changed: 2020-12-02
Basic data Employees H: 10,001 to 50,00 (2021-12-14)
    * Document for »About Section«: Vifor Pharma AG. (12/14/21). "Press Release: CSL Limited Announces Tender Offer to Acquire Vifor Pharma Ltd (ad hoc)". St. Gallen.
Record changed: 2023-07-10


Picture EBD Group BIO-Europe 2024 Stockholm BEU24 650x200px

More documents for CSL (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture EBD Group World of Partnering Opportunities 650x300px

» top